Stanford Technology Ventures Program : Russ Altman

Russ Altman, Stanford University Kim Branson, GSK

Principled Engineering: AI and Drug Development [Entire Talk]

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Video 58 minutes

Russ Altman , Stanford University Kim Branson , GSK

Principled Engineering: AI and Drug Development [Entire Talk]

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Video Clips

ETL Entrepreneurial Thought Leaders Podcast

Russ Altman, Stanford University Kim Branson, GSK

Principled Engineering: AI and Drug Development

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Podcast 59 minutes

Clip 1 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk]

Russ Altman, Stanford University Kim Branson, GSK

Where is AI-Driven Bioengineering Headed Next?

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Video Clip 3 minutes

Clip 2 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk]

Russ Altman, Stanford University Kim Branson, GSK

Innovation-Driven Engagement with Regulators

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Video Clip 9 minutes

Clip 3 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk]

Russ Altman, Stanford University Kim Branson, GSK

Ethical Science is Better Science

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Video Clip 3 minutes

Clip 4 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk]

Russ Altman, Stanford University Kim Branson, GSK

Ethical Guardrails for AI in Drug Development

AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.

Video Clip 3 minutes